Dengue Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
세계 뎅기열 검사 시장 규모는 2025년 5억 8,350만 달러에 달할 것으로 예상되며, 2025-2032년의 예측 기간 동안 5.8%의 연평균 복합 성장률(CAGR)로 성장하여 2032년에는 8억 6,580만 달러에 달할 것으로 예측되고 있습니다.
뎅기열 검사 시장에는 감염이 의심되는 개인에게서 뎅기열 바이러스의 존재를 감지하는 데 사용되는 진단 검사가 포함되어 있습니다. 열대 및 아열대지역에서 뎅기열의 발생이 증가하고 있는 것 외에 헬스케어에 대한 의식의 고조나 진단 기술의 진보에 의해 조사 시장은 안정된 성장을 이루고 있습니다.
뎅기열 검사 시장의 성장은 주로 바이러스를 전파하는 숲모기가 많은 열대 및 아열대지역에서 뎅기열의 유행이 증가하면서 견인되고 있습니다. 조기 발견과 관리에 대한 수요 증가는 의료시설에 첨단 진단 기술의 도입을 촉구하고 있습니다. 또한, 뎅기열의 발생을 억제하고 헬스케어 인프라를 개선하기 위한 정부의 대처와 포인트 오브 케어(POC) 진단 툴의 채용이 증가하고 있는 것도 시장을 견인하는 주요 요인이 되고 있습니다.
뎅기열 검사에 대한 수요가 증가함에도 불구하고 일부 요인이 시장 성장을 억제하고 있습니다. 격오지에서는 인프라 및 숙련 인력의 부족으로 효과적인 검사가 어렵습니다. 또, 검사법의 차이에 의한 진단 정밀도의 편차나, 검사의 이용 가능성이나 품질 관리에 관한 과제도 시장을 압박하고 있습니다. 또한, 지역에 따라서는 조기 진단의 중요성에 대한 인식이 낮기 때문에 검사가 늦어지고 시장 전체의 성장에 영향을 주고 있습니다.
뎅기열 검사 시장은 특히 높은 감도와 특이성을 제공하는 RT-PCR과 같은 분자 진단 기술의 진보로 큰 성장 기회를 가져오고 있습니다. 다중 진단 키트의 개발이 주목을 받으면서 시장 확대의 원동력이 될 가능성이 있습니다. 남미, 라틴아메리카 등 뎅기열이 자주 발생하는 지역의 신흥 시장은 시장 참가자에게 유리한 기회를 제공합니다.
이 보고서는 세계의 뎅기열 검사 시장에 대해 조사했으며, 제품 유형별, 최종 사용자별, 지역별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.
목차
제1장 주요 요약
제2장 시장 개요
- 시장의 범위와 정의
- 시장 역학
- COVID-19의 영향 분석
- 예측 요인 - 관련성과 영향
제3장 부가가치 인사이트
제4장 세계의 뎅기열 검사 시장 전망
- 주요 하이라이트
- 시장 규모 분석과 예측
- 과거 시장 규모 분석(2019-2024년)
- 현재 시장 규모 분석과 예측(2025-2032년)
- 세계의 뎅기열 검사 시장 전망 : 제품 유형별
- 과거 시장 규모 분석, 제품 유형별(2019-2024년)
- 현재 시장 규모 분석과 예측, 제품 유형별(2025-2032년)
- 시장의 매력 분석 : 제품 유형별
- 세계의 뎅기열 검사 시장 전망 : 최종 사용자별
- 과거 시장 규모 분석, 최종 사용자별(2019-2024년)
- 현재 시장 규모 분석과 예측, 최종 사용자별(2025-2032년)
- 시장의 매력 분석 : 최종 사용자별
제5장 세계의 뎅기열 검사 시장 전망 : 지역별
- 과거 시장 규모 분석, 지역별(2019-2024년)
- 현재 시장 규모 분석과 예측, 지역별(2025-2032년)
- 북미
- 라틴아메리카
- 유럽
- 동아시아
- 남아시아와 오세아니아
- 중동 및 아프리카
- 시장의 매력 분석 : 지역별
제6장 북미의 뎅기열 검사 시장 전망
제7장 유럽의 뎅기열 검사 시장 전망
제8장 동아시아의 뎅기열 검사 시장 전망
제9장 남아시아 및 오세아니아의 뎅기열 검사 시장 전망
제10장 라틴아메리카의 뎅기열 검사 시장 전망
제11장 중동 및 아프리카의 뎅기열 검사 시장 전망
제12장 경쟁 구도
- 시장 점유율 분석(2025년)
- 시장 구조
- 기업 프로파일(상세 - 개요, 재무, 전략, 최근 동향)
- Thermo Fisher Scientific Inc.
- Abnova Corporation
- Roche Molecular Systems Inc.
- Abbott Laboratories
- InBios International, Inc.
- NovaTec Immundiagnostica GmbH
- Euroimmun AG(Sub. PerkinElmer)
- Quest Diagnostics
- Certest Biotec SL
- OriGene Technologies
- Jiangsu BioPerfectus Technologies Co., Ltd
- Vitrosens Biyoteknoloji A.
- ACON Biotech(Hangzhou) Co., Ltd.
- Biozek
- Mankind Pharma Pvt Ltd
- Sun Pharmaceutical Industries Ltd
- 기타
제13장 부록
CSM
Persistence Market Research has recently released a comprehensive report on the global Dengue Testing Market, offering an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report provides a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.
Key Insights:
- Dengue Testing Market Size (2025E): US$ 583.5 Mn
- Projected Market Value (2032F): US$ 865.8 Mn
- Global Market Growth Rate (CAGR 2025 to 2032): 5.8%
Dengue Testing Market - Report Scope:
The Dengue Testing Market includes diagnostic tests used to detect the presence of the dengue virus in individuals suspected of being infected. These tests help determine whether a patient has dengue fever, which is caused by the dengue virus transmitted through mosquito bites. With increasing incidences of dengue in tropical and subtropical regions, along with rising healthcare awareness and advancements in diagnostic technology, the market is experiencing steady growth. The market includes a variety of testing methods such as ELISA-based tests, RT-PCR tests, and dengue rapid tests, which are primarily used in hospitals, diagnostic centers, and public health laboratories.
Market Growth Drivers:
The growth of the Dengue Testing Market is primarily driven by the increasing prevalence of dengue fever in tropical and subtropical regions, where the Aedes mosquitoes that transmit the virus are common. Global climate change, urbanization, and population mobility contribute to the rising number of dengue cases, making rapid and accurate diagnostics crucial. The growing demand for early detection and management of dengue fever is prompting healthcare facilities to adopt advanced diagnostic technologies. Furthermore, government initiatives to control dengue outbreaks and improve healthcare infrastructure, coupled with the rising adoption of point-of-care (POC) diagnostic tools, are key factors driving the market.
Market Restraints:
Despite the growing demand for dengue testing, several factors are restraining market growth. The high cost of diagnostic tests, particularly in low-income countries, limits the widespread adoption of advanced testing technologies. Additionally, the lack of infrastructure and trained personnel in remote and rural areas hampers the effective implementation of testing strategies. The variability in diagnostic accuracy between different testing methods, as well as challenges related to test availability and quality control, also poses challenges for the market. Moreover, limited awareness about the importance of early diagnosis in certain regions contributes to delayed testing, thereby impacting overall market growth.
Market Opportunities:
The Dengue Testing Market presents significant growth opportunities, particularly with advancements in molecular diagnostic techniques like RT-PCR, which offer higher sensitivity and specificity. The growing trend towards automation in laboratories and diagnostic centers presents an opportunity for the development of more efficient and faster testing solutions. Additionally, there is a growing focus on the development of multiplex diagnostic kits capable of detecting multiple infectious diseases, including dengue, which could drive market expansion. Emerging markets in regions like South Asia, Latin America, and Africa, where dengue outbreaks are frequent, provide a lucrative opportunity for market players. Increased investment in public health initiatives and the development of cost-effective testing options will further open up opportunities for market growth.
Key Questions Answered in the Report:
- What are the primary factors driving the global dengue testing market's growth?
- Which regions and market segments are experiencing the highest demand for dengue testing?
- How are innovations in diagnostic technologies influencing market dynamics?
- Who are the key players in the dengue testing market, and what strategies are they adopting to stay competitive?
- What are the emerging trends and future projections for the global dengue testing market?
Competitive Intelligence and Business Strategy:
Leading companies in the global dengue testing market, such as Abnova Corporation, Roche Molecular Systems Inc., Abbott Laboratories, InBios International, Inc., and others, are focusing on product innovation, strategic partnerships, and expanding their global presence. These companies are investing in research and development to improve the sensitivity and specificity of dengue tests. They are also exploring opportunities to expand their market reach through partnerships with public health organizations and diagnostic centers. Collaborating with governmental health agencies to provide affordable diagnostic solutions in endemic regions is becoming a key strategic focus to enhance market penetration.
Companies Covered in This Report:
- Abnova Corporation
- Roche Molecular Systems Inc.
- Abbott Laboratories
- InBios International, Inc.
- NovaTec Immundiagnostica GmbH
- Euroimmun AG (Sub. PerkinElmer)
- Quest Diagnostics
- Certest Biotec S.L.
- OriGene Technologies
Dengue Testing Market Segmentation:
By Product Type:
- ELISA-based Tests
- RT-PCR based Tests
- Dengue IgG/IgM Rapid Test
- Others
By End-User:
- Hospitals
- Public Health Laboratories
- Diagnostic Centers
- Others
By Region:
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global Dengue Testing Market Snapshot, 2025-2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. COVID-19 Impact Analysis
- 2.4. Forecast Factors - Relevance and Impact
3. Value Added Insights
- 3.1. Value Chain Analysis
- 3.2. Technology Adoption / Usage Analysis
- 3.3. Diseases Epidemiology
- 3.4. Key Market Players
- 3.5. Regulatory Landscape
- 3.6. PESTLE Analysis
- 3.7. Porter's Five Forces Analysis
- 3.8. Consumer Behavior Analysis
4. Global Dengue Testing Market Outlook
- 4.1. Key Highlights
- 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
- 4.2. Market Size (US$ Mn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
- 4.3. Global Dengue Testing Market Outlook: Product Type
- 4.3.1. Historical Market Size (US$ Mn) Analysis, By Product Type, 2019-2024
- 4.3.2. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
- 4.3.2.1. ELISA-based Tests
- 4.3.2.2. RT-PCR based Tests
- 4.3.2.3. Dengue IgG/IgM Rapid Test
- 4.3.2.4. Others
- 4.3.3. Market Attractiveness Analysis: Technology
- 4.4. Global Dengue Testing Market Outlook: End-User
- 4.4.1. Historical Market Size (US$ Mn) Analysis, By End-User, 2019-2024
- 4.4.2. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
- 4.4.2.1. Hospitals
- 4.4.2.2. Public Health Laboratory
- 4.4.2.3. Diagnostic Centers
- 4.4.2.4. Others
- 4.4.3. Market Attractiveness Analysis: End-User
5. Global Dengue Testing Market Outlook Region
- 5.1. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
- 5.2. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2025-2032
- 5.2.1. North America
- 5.2.2. Latin America
- 5.2.3. Europe
- 5.2.4. East Asia
- 5.2.5. South Asia and Oceania
- 5.2.6. Middle East & Africa
- 5.3. Market Attractiveness Analysis: Region
6. North America Dengue Testing Market Outlook
- 6.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 6.1.1. By Country
- 6.1.2. By Product Type
- 6.1.3. By End-User
- 6.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 6.2.1. U.S.
- 6.2.2. Canada
- 6.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 6.3.1. ELISA-based Tests
- 6.3.2. RT-PCR based Tests
- 6.3.3. Dengue IgG/IgM Rapid Test
- 6.3.4. Others
- 6.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 6.4.1. Hospitals
- 6.4.2. Public Health Laboratory
- 6.4.3. Diagnostic Centers
- 6.4.4. Others
- 6.5. Market Attractiveness Analysis
7. Europe Dengue Testing Market Outlook
- 7.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.1.1. By Country
- 7.1.2. By Product Type
- 7.1.3. By End-User
- 7.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 7.2.1. Germany
- 7.2.2. France
- 7.2.3. U.K.
- 7.2.4. Italy
- 7.2.5. Spain
- 7.2.6. Russia
- 7.2.7. Rest of Europe
- 7.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 7.3.1. ELISA-based Tests
- 7.3.2. RT-PCR based Tests
- 7.3.3. Dengue IgG/IgM Rapid Test
- 7.3.4. Others
- 7.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 7.4.1. Hospitals
- 7.4.2. Public Health Laboratory
- 7.4.3. Diagnostic Centers
- 7.4.4. Others
- 7.5. Market Attractiveness Analysis
8. East Asia Dengue Testing Market Outlook
- 8.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.1.1. By Country
- 8.1.2. By Product Type
- 8.1.3. By End-User
- 8.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 8.2.1. China
- 8.2.2. Japan
- 8.2.3. South Korea
- 8.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 8.3.1. ELISA-based Tests
- 8.3.2. RT-PCR based Tests
- 8.3.3. Dengue IgG/IgM Rapid Test
- 8.3.4. Others
- 8.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 8.4.1. Hospitals
- 8.4.2. Public Health Laboratory
- 8.4.3. Diagnostic Centers
- 8.4.4. Others
- 8.5. Market Attractiveness Analysis
9. South Asia & Oceania Dengue Testing Market Outlook
- 9.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.1.1. By Country
- 9.1.2. By Product Type
- 9.1.3. By End-User
- 9.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 9.2.1. India
- 9.2.2. Indonesia
- 9.2.3. Thailand
- 9.2.4. Singapore
- 9.2.5. ANZ
- 9.2.6. Rest of South Asia & Oceania
- 9.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 9.3.1. ELISA-based Tests
- 9.3.2. RT-PCR based Tests
- 9.3.3. Dengue IgG/IgM Rapid Test
- 9.3.4. Others
- 9.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 9.4.1. Hospitals
- 9.4.2. Public Health Laboratory
- 9.4.3. Diagnostic Centers
- 9.4.4. Others
- 9.5. Market Attractiveness Analysis
10. Latin America Dengue Testing Market Outlook
- 10.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.1.1. By Country
- 10.1.2. By Product Type
- 10.1.3. By End-User
- 10.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 10.2.1. Brazil
- 10.2.2. Mexico
- 10.2.3. Rest of Latin America
- 10.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 10.3.1. ELISA-based Tests
- 10.3.2. RT-PCR based Tests
- 10.3.3. Dengue IgG/IgM Rapid Test
- 10.3.4. Others
- 10.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 10.4.1. Hospitals
- 10.4.2. Public Health Laboratory
- 10.4.3. Diagnostic Centers
- 10.4.4. Others
- 10.5. Market Attractiveness Analysis
11. Middle East & Africa Dengue Testing Market Outlook
- 11.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.1.1. By Country
- 11.1.2. By Product Type
- 11.1.3. By End-User
- 11.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 11.2.1. GCC Countries
- 11.2.2. Egypt
- 11.2.3. South Africa
- 11.2.4. Northern Africa
- 11.2.5. Rest of Middle East & Africa
- 11.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 11.3.1. ELISA-based Tests
- 11.3.2. RT-PCR based Tests
- 11.3.3. Dengue IgG/IgM Rapid Test
- 11.3.4. Others
- 11.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 11.4.1. Hospitals
- 11.4.2. Public Health Laboratory
- 11.4.3. Diagnostic Centers
- 11.4.4. Others
- 11.5. Market Attractiveness Analysis
12. Competition Landscape
- 12.1. Market Share Analysis, 2025
- 12.2. Market Structure
- 12.2.1. Competition Intensity Mapping by Market
- 12.2.2. Competition Dashboard
- 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Thermo Fisher Scientific Inc.
- 12.3.1.1. Overview
- 12.3.1.2. Segments and Sources
- 12.3.1.3. Key Financials
- 12.3.1.4. Market Developments
- 12.3.1.5. Market Strategy
- 12.3.2. Abnova Corporation
- 12.3.3. Roche Molecular Systems Inc.
- 12.3.4. Abbott Laboratories
- 12.3.5. InBios International, Inc.
- 12.3.6. NovaTec Immundiagnostica GmbH
- 12.3.7. Euroimmun AG (Sub. PerkinElmer)
- 12.3.8. Quest Diagnostics
- 12.3.9. Certest Biotec S.L.
- 12.3.10. OriGene Technologies
- 12.3.11. Jiangsu BioPerfectus Technologies Co., Ltd
- 12.3.12. Vitrosens Biyoteknoloji A.
- 12.3.13. ACON Biotech (Hangzhou) Co., Ltd.
- 12.3.14. Biozek
- 12.3.15. Mankind Pharma Pvt Ltd
- 12.3.16. Sun Pharmaceutical Industries Ltd
- 12.3.17. Others
13. Appendix
- 13.1. Research Methodology
- 13.2. Research Assumptions
- 13.3. Acronyms and Abbreviations
